Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels
about
Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysisExtracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biologyAngiogenesis and Antiangiogenesis in Triple-Negative Breast cancerCathepsin G-mediated enhanced TGF-beta signaling promotes angiogenesis via upregulation of VEGF and MCP-1.Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model.Molecular diversity of VEGF-A as a regulator of its biological activity.Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.Identification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing.Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions.Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics.NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivoDecreased efficacy of drugs targeting the vascular endothelial growth factor pathway by the epigenetic silencing of FLT1 in renal cancer cells.Pro- and anti-angiogenic VEGF mRNAs in autoimmune thyroid diseases.Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.Expression of livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma.Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.Vascular remodeling in cancer.New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation.On-line surface plasmon resonance biosensing of vascular endothelial growth factor signaling in intact-human hepatoma cell lines.Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells.Exploiting the tumor microenvironment in the development of targeted cancer gene therapy.Expression, purification and functionality of bioactive recombinant human vascular endothelial growth factor VEGF165 in E. coli.Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.Multiscale Modeling of Glioblastoma Suggests that the Partial Disruption of Vessel/Cancer Stem Cell Crosstalk Can Promote Tumor Regression Without Increasing Invasiveness.Overexpression of VEGF183 promotes murine breast cancer cell proliferation in vitro and induces dilated intratumoral microvessels.Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma.
P2860
Q21202775-E90C1E3F-7554-4943-9208-C91D1A0869C5Q27000351-BDE120BA-8BB3-4829-939A-FA81F1C35214Q27022814-44640301-31B5-4A81-AA6D-AB822954D3B3Q28079013-B1535B6A-CF59-46A4-A253-2D08897A46C2Q33625023-9C45F40A-2A85-4D08-BFDA-E913D28B2389Q33649673-54AA956B-95F6-41DA-8EEC-26A20C7DA2C6Q34089123-450BC02A-AAD5-493A-8052-E4C9FBAC1830Q34606479-B25FF9B6-26BE-4EDE-AFF1-828CD3B93883Q34712017-B44CCA32-827D-4339-B453-89A0AF33B510Q35534079-5E44E5AD-7ED9-442D-8551-4E1FB6302DD6Q35923316-84B76244-F7D3-4DD4-8636-D25D7E9B0722Q36027061-14E2A913-8D68-4627-9E7D-4A09EAEBEECAQ36058744-22708C4F-DFEA-429C-BA88-CE9D21A56044Q36067203-9E252C4A-00F0-4953-B277-EF68AA1E19B5Q36095767-ECB5D5DA-34D4-4857-BC05-160E6E370E06Q36542090-7467E237-9272-4F1B-A268-A4744E4CBB4DQ37356468-AF09BD97-1B29-497A-9A6A-03F6C2F3D8E5Q37997765-D0664220-E53F-4B39-9281-E0CDD887564BQ38126351-01BFDC29-20A5-40C7-9B3A-81D7BBA151FDQ38319139-98647705-E610-40B7-ACCA-0E65A7B04B78Q39028572-5933C0B3-9734-4B15-ADC3-A012C158A1E9Q39730398-21AB3F87-A787-47F7-9FDB-238917727832Q39935539-6D24D226-1A44-4047-BFEA-46EA38B479D8Q42323662-2415588C-093F-416E-BB1E-1B3CA85C1E4CQ46888149-595CD784-AF57-4D31-85ED-FCD32D57BDD8Q50352642-91C68075-5210-494C-8978-6C9B9FD1ECCFQ53647598-977A309E-3765-4238-97BF-E1D3E08D6789Q55257606-22351B29-0454-4AA5-B0B7-25982EEBF374
P2860
Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Overexpression of vascular end ...... h dilated intratumoral vessels
@ast
Overexpression of vascular end ...... h dilated intratumoral vessels
@en
type
label
Overexpression of vascular end ...... h dilated intratumoral vessels
@ast
Overexpression of vascular end ...... h dilated intratumoral vessels
@en
prefLabel
Overexpression of vascular end ...... h dilated intratumoral vessels
@ast
Overexpression of vascular end ...... h dilated intratumoral vessels
@en
P2093
P2860
P1476
Overexpression of vascular end ...... h dilated intratumoral vessels
@en
P2093
Guillaume Velasco
Gérard Perret
Hélène Buteau-Lozano
Ivan Bieche
Marie-Astrid Hervé
Marika Pla
Martine Perrot-Applanat
Roger Vassy
Samia Mourah
P2860
P304
P356
10.2353/AJPATH.2008.070181
P407
P577
2007-12-13T00:00:00Z